NSC109268 potentiates cisplatin-induced cell death in a p53-independent manner

BACKGROUND: Ovarian cancer is the leading cause of death among gynecological cancers. Cisplatin is one of the most effective anticancer drugs used in the treatment of ovarian cancer. Development of resistance to cisplatin limits its therapeutic use. Most of the anticancer drugs, including cisplatin,...

Descripción completa

Detalles Bibliográficos
Autores principales: Shankar, Eswar, Basu, Chandreyi, Adkins, Brett, Siede, Wolfram, Basu, Alakananda
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Research article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2889948/
https://www.ncbi.nlm.nih.gov/pubmed/20459745
http://dx.doi.org/10.1186/1750-2187-5-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2889948/
https://www.ncbi.nlm.nih.gov/pubmed/20459745
http://dx.doi.org/10.1186/1750-2187-5-4

Ejemplares similares